2025 Third Quarter Financial Summary and 2025 Earnings Outlook

Overview of 2025 Third Quarter Financial Results

Net sales for the third quarter of 2025 were 659.9 billion yen, a decrease of 96.2 billion yen compared to the same period last year. Operating income was 23.8 billion yen, down 1.8 billion yen YoY. The healthcare business increased profits due to higher rental volumes and increased license fee revenues; however, profits declined in the materials business due to the impact of major maintenance shutdowns and deterioration in sales mix, as well as exclusion of profit and loss from the aramid paper business. Impairment losses were also recorded due to the temporary suspension of the U.S. carbon fiber plant, resulting in a quarterly loss of 59 billion yen.

2025 Earnings Outlook and Highlights

The operating income forecast for 2025 remains unchanged at 25 billion yen. The annual dividend is planned at 50 yen per share (25 yen interim and 25 yen year-end), with no changes. Full-year net sales are expected to decline by 1.455 trillion yen, operating income to decrease by 2.6 billion yen, and net income attributable to owners of the parent to drop by 38.3 billion yen. A highlight includes the planned conclusion of a contract in December 2025 for a business integration (joint venture establishment) between Teijin Frontier Co., Ltd. and Asahi Kasei Advance Corporation.